PEAK6 Investments’s DarioHealth DRIO Stock Holding History

PEAK6 Investments’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-978	Closed	-$91K	–	4607
2022 Q3	$91K	Buy	+978	New	+$105K	﹤0.01%	4135

Other funds holding DRIO

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PEAK6 Investments's DRIO Position: Q4 2022 in Review

PEAK6 Investments sold out of DarioHealth (DRIO) in Q4 2022, closing a stake of 978 shares — an estimated $91K sold.

PEAK6 Investments first reported a position in DRIO in Q3 2022 and held it in 1 quarter. The position peaked at $91K in Q3 2022. 46 funds tracked by Wall St. Rank hold DRIO as of Q4 2022.

PEAK6 Investments reported no remaining DarioHealth position as of Q4 2022 after selling out during the quarter.
PEAK6 Investments sold 978 DarioHealth shares in Q4 2022, an estimated $91K.
PEAK6 Investments first reported a position in DarioHealth in Q3 2022 and held it in 1 quarter.
PEAK6 Investments's DarioHealth position peaked at $91K in Q3 2022.
46 funds tracked by Wall St. Rank held DarioHealth as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.